Similar articles

• Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP.

  Lauster F, Gerzer R, Weil J, Fülle HJ, Schiffl H. Lauster F, et al. Nephrol Dial Transplant. 1990;5(5):356-61. doi: 10.1093/ndt/5.5.356. Nephrol Dial Transplant. 1990. PMID: 2165225
• Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.

  Lettgen B, Bald M, Valleé H, Bonzel KE, Rascher W. Lettgen B, et al. Pediatr Nephrol. 1992 Jan;6(1):60-4. doi: 10.1007/BF00856837. Pediatr Nephrol. 1992. PMID: 1311187
• Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.

  Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Osajima A, et al. Am J Nephrol. 2001 Mar-Apr;21(2):112-9. doi: 10.1159/000046233. Am J Nephrol. 2001. PMID: 11359018
• New techniques to determine fluid status in hemodialyzed patients.

  Leunissen KM, Kouw P, Kooman JP, Cheriex EC, deVries PM, Donker AJ, van Hooff JP. Leunissen KM, et al. Kidney Int Suppl. 1993 Jun;41:S50-6. Kidney Int Suppl. 1993. PMID: 8391607 Review.
• Living on chronic hemodialysis between dryness and fluid overload.

  Franz M, Pohanka E, Tribl B, Woloszczuk W, Hörl WH. Franz M, et al. Kidney Int Suppl. 1997 Jun;59:S39-42. Kidney Int Suppl. 1997. PMID: 9185103 Review.